홈SHPMY • OTCMKTS
add
상해제약그룹
시장 뉴스
재무
손익계산서
수익
순이익
| (CNY) | 2024년 3월info | 전년대비 변동 |
|---|---|---|
수익 | 701.53억 | 5.93% |
운영비 | 56.50억 | -4.06% |
순이익 | 15.42억 | 1.62% |
순이익률 | 2.20 | -3.93% |
주당 수익 | — | — |
EBITDA | 27.13억 | -13.23% |
유효 세율 | 22.80% | — |
대차대조표
총자산
총부채
| (CNY) | 2024년 3월info | 전년대비 변동 |
|---|---|---|
현금 및 단기 투자 | 371.75억 | -2.45% |
총자산 | 2174.17억 | 5.52% |
총부채 | 1353.31억 | 7.27% |
총자기자본 | 820.86억 | — |
발행 주식 | 37.03억 | — |
주가순자산비율 | 0.40 | — |
총자산이익률 | 2.77% | — |
자본이익률 | 4.41% | — |
현금 흐름
순현금흐름
| (CNY) | 2024년 3월info | 전년대비 변동 |
|---|---|---|
순이익 | 15.42억 | 1.62% |
영업 현금 흐름 | -54.74억 | -108.65% |
투자 현금 흐름 | 18.42억 | 187.44% |
자금 조달 현금 흐름 | 32.50억 | -24.64% |
순현금흐름 | -3.74억 | 12.88% |
잉여 현금 흐름 | -78.32억 | -33.74% |
정보
Shanghai Pharmaceuticals is a Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
설립
1994. 1. 18.
웹사이트
직원 수
48,164
